Blocking NF-κB can cause tumor cells to stop proliferating, to die, or to become more sensitive to the action of anti-tumor agents.
O bloqueo do NF-κB pode causar que as células tumorais deixen de proliferar, morran, ou sexan máis sensibles á acción dos axentes anti-tumorais.